PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026
"The Report PharmaPoint:
Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
About
Type
2 Diabetes
Market
While the global T2D market is
crowded with inexpensive generics and marked by a pipeline filled
with me-too drugs, GlobalData expects this market to undergo
substantial growth between 2016 and 2026, doubling over the forecast
period. The main driver of this enormous expansion will be the
dramatic increase in disease prevalence, which is attributable to
increased life expectancy and an increasingly sedentary and stressful
lifestyle. The second largest driver will be physicians efforts to
delay disease progression and reduce the costly burden of diabetic
complications through the use of combination therapies and novel
branded drugs.
Get Sample copy of this Report
@ https://www.marketresearchreports.biz/sample/sample/1350131
Despite the large number of
marketed therapies, the T2D market is still experiencing large unmet
needs and therefore has a significant growth opportunity for new
patent-protected products. Metformin (dimethylbiguanide) will remain
the first-line therapy overall for T2D due to physicians familiarity
with it and the availability of long-term data, but the usage of
sulfonylureas (SUs), another front-line therapy, continues to be
replaced by novel therapies with improved side-effect profiles. The
battle for second- or third-line therapy will involve DPP-4Is,
GLP-1RAs, SGLT-Is, and other upcoming novel therapies. Of all the
currently marketed classes, GLP-1RAs and SGLT-Is will experience the
fastest growth due to their beneficial CV effects, weight-loss
effects, and increasing ease of use.
Scope
- Overview of T2D, including
epidemiology, etiology, pathophysiology, symptoms, diagnosis, and
treatment guidelines.
- Annualized T2D therapeutics
market revenue, annual cost of therapy and treatment usage pattern
data from 2016 and forecast for ten years to 2026.
- Key topics covered include
strategic competitor assessment, market characterization, unmet
needs, clinical trial mapping and implications for the T2D
therapeutics market.
- Pipeline analysis: comprehensive
data split across different phases, emerging novel trends under
development, and detailed analysis of late-stage pipeline drugs.
-
Analysis of the current and future market competition in the global
T2D therapeutics market. Insightful review of the key industry
drivers, restraints and challenges. Each trend is independently
researched to provide qualitative analysis of its implications.
View
Report @
https://www.marketresearchreports.biz/reports/1350131/pharmapoint-type-diabetes-global-market-research-reports
Reasons to buy
The report will enable you to -
- Develop and design your
in-licensing and out-licensing strategies through a review of
pipeline products and technologies, and by identifying the companies
with the most robust pipeline. Additionally a list of acquisition
targets included in the pipeline product company list.
- Develop business strategies by
understanding the trends shaping and driving the global T2D
therapeutics market.
- Drive revenues by understanding
the key trends, innovative products and technologies, market
segments, and companies likely to impact the global T2D therapeutics
market in future.
- Formulate effective sales and
marketing strategies by understanding the competitive landscape and
by analysing the performance of various competitors.
- Identify emerging players with
potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Track drug sales in the global
T2D therapeutics market from 2016-2026.
- Organize your sales and
marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments
and strategic partnerships.
Send
An Enquiry Request @
https://www.marketresearchreports.biz/sample/enquiry/1350131
Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 10
2 Type 2 Diabetes (T2D): Executive
Summary 11
2.1 T2D Sales to Double Across 7MM
12
2.2 Multiple Opportunities Exist
to Address Existing T2D Market Unmet Needs 14
2.3 The Arrival of Insulin
Biosimilars and Abundance of Me-Too Drugs Illustrates Corporate Shift
in Focus from Therapeutic Value Towards Competitive Pricing and
Non-novel Agents that Confer Incremental Benefits 18
2.4 Glucagon-Like Peptide -1
Receptor Agonist Class Faces Intense Internal Competition, Largely
Revolving Around Drugs Ability to Improve Patient Compliance/Ease of
Administration and Cardiovascular Effects 19
2.5 Newest T2D Drug Class,
Sodium-Glucose Cotransporter Inhibitors, Will Continue To Gain
Significant Market Share Despite Concerns 19
2.6 What Do Physicians Think? 20
3 Introduction 23
3.1 Catalyst 23
3.2 Related Reports 24
4 Disease Overview 25
4.1 Etiology 25
4.2 Pathophysiology 27
4.3 Symptoms 29
4.4 Prognosis 31
4.5 Quality of Life 31
5 Epidemiology 31
5.1 Disease Background 32
5.2 Risk Factors and Comorbidities
32
5.3 Global and Historical Trends
34
5.4 Forecast Methodology 35
5.4.1 Sources Used 36
5.4.2 Forecast Assumptions and
Methods 39
5.5 Epidemiological Forecast for
T2D in the 8MM (2016-2026) 48
5.5.1 Diagnosed Prevalent Cases of
T2D 48
5.5.2 Age-Specific Diagnosed
Prevalent Cases of T2D 49
5.5.3 Sex-Specific Diagnosed
Prevalent Cases of T2D 49
5.5.4 Comorbidities Among the
Diagnosed Prevalent Cases of T2D 50
5.6 Discussion 54
5.6.1 Epidemiological Forecast
Insight 54
5.6.2 Limitations of Analysis 55
5.6.3 Strengths of Analysis 55
6 Disease Management 57
6.1 Diagnosis and Treatment
Overview 57
6.1.1 Diagnosis and Referrals 57
6.1.2 Treatment Guidelines and
Leading Prescribed Drugs 58
6.1.3 Clinical Practice 63
6.2 US 64
6.3 France 66
6.4 Germany 68
6.5 Italy 71
6.6 Spain 75
6.7 UK 78
6.8 Japan 82
About us
MarketResearchReports.biz is the
most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Comments
Post a Comment